University of Texas at Austin
CRISPR-Associated Nuclease Degrades RNA, DNA to Impair Cell Growth; Promises Use in Biotech
The nuclease, dubbed Cas12a2, is described in two new papers and could potentially be used in a range of biotechnological applications, including as a diagnostic.
Engineered Cas9 Enzyme Less Likely to Make Off-Target Cuts, Still Efficient
After analyzing Cas9 conformations at different points during mismatch cleavage, researchers developed a new enzyme to avoid such cuts.
An ABRF working group compared three dyes for Sanger sequencing to find that, even with their differences in price, they all performed similarly.
CRISPR Study Shows Cas12a May Select DNA Target Sequences More Precisely Than Cas9
The researchers showed that Cas12a discriminates strongly against mismatches to DNA targets, leading to less off-target DNA cleavage than with Cas9.
ABRF Speakers Outline Disaster Prep for Core Facilities
Speakers at the Association for Biomolecular Resource Facilities annual meeting gave advice on preparing for and recovering from hurricanes.
Dec 5, 2014
Jul 31, 2014
Genomics in the Journals: Arrays 2014.07.31
May 15, 2014
Genomics in the Journals May 15, 2014
Nov 19, 2013
Mar 14, 2013
Mar 14, 2013
Sep 20, 2012
UT-Austin Scientist Snags $2.5M NIH Pioneer Award
Jan 31, 2012
Sep 27, 2011
Bioo, Jungwoo Partner on Cancer MDx Technologies
Sep 15, 2010